share_log

Lilly and Novo Nordisk Shares Are Trading Lower Following a Weight Loss Drug Update From Amgen.

Benzinga ·  May 3 20:20
Lilly and Novo Nordisk Shares Are Trading Lower Following a Weight Loss Drug Update From Amgen.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment